HEALTHCARE ROYALTY PARTNERS — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Aptevo TherapeuticsNASDAQ: APVOApr 2025
BiotechSeattle, US
Marvin L White(Executive Officer, Director)
Co-investorsYorkville Advisors
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.